ArticleFrontiers in oncology2026

Trastuzumab deruxtecan in advanced breast cancer: a real-world study of efficacy and safety in Chinese cohort with HER2-positive and HER2-low expression.

Hainan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.